-
3
-
-
0034817278
-
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience
-
HAN M, PARTIN AW, POUND CR, EPSTEIN JI, WALSH PC: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol. Clin. North. Am. (2001) 28:555-565.
-
(2001)
Urol. Clin. North. Am.
, vol.28
, pp. 555-565
-
-
Han, M.1
Partin, A.W.2
Pound, C.R.3
Epstein, J.I.4
Walsh, P.C.5
-
4
-
-
4744366279
-
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
-
TANNOCK IF, DE WIT R, BERRY WR et al.: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N. Engl. J. Med. (2004) 351:1502-1512.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 1502-1512
-
-
Tannock, I.F.1
De Wit, R.2
Berry, W.R.3
-
5
-
-
4744337716
-
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
-
PETRYLAK DP, TANGEN CM, HUSSAIN MH et al: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N. Engl. J. Med. (2004) 351:1513-1520.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 1513-1520
-
-
Petrylak, D.P.1
Tangen, C.M.2
Hussain, M.H.3
-
6
-
-
15844429706
-
Mechanisms of the development of androgen independence in prostate cancer
-
SO A, GLEAVE M, HURTADO-COL A, NELSON C: Mechanisms of the development of androgen independence in prostate cancer. World J. Urol. (2005) 23:1-9.
-
(2005)
World J. Urol.
, vol.23
, pp. 1-9
-
-
So, A.1
Gleave, M.2
Hurtado-col, A.3
Nelson, C.4
-
7
-
-
0033215472
-
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process
-
CRAFT N, CHHOR C, TRAN C et al.: Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res. (1999) 59:5030-5036.
-
(1999)
Cancer Res.
, vol.59
, pp. 5030-5036
-
-
Craft, N.1
Chhor, C.2
Tran, C.3
-
8
-
-
0030841919
-
Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and Ap- l /c-Jun in the human prostate cancer cell line LNCaP
-
SATO N, SADAR MD, BRUCHOVSKY N et al: Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and Ap- l/c-Jun in the human prostate cancer cell line LNCaP. J. Biol. Chem. (1997) 272:17485-17494.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 17485-17494
-
-
Sato, N.1
Sadar, M.D.2
Bruchovsky, N.3
-
9
-
-
0036510548
-
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
-
UEDA T, BRUCHOVSKY N, SADAR MD: Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J. Biol. Chem. (2002) 277:7076-7085.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 7076-7085
-
-
Ueda, T.1
Bruchovsky, N.2
Sadar, M.D.3
-
10
-
-
12144288184
-
Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells
-
BLASZCZYK N, MASRI BA, MAWJI NR et al.: Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells. Clin. Cancer Res. (2004) 10:1860-1869.
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 1860-1869
-
-
Blaszczyk, N.1
Masri, B.A.2
Mawji, N.R.3
-
11
-
-
10744227995
-
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases
-
UEHARA H, KIM SJ, KARASHIMA T et al.: Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J. Natl. Cancer Inst. (2003) 95:458-470.
-
(2003)
J. Natl. Cancer Inst.
, vol.95
, pp. 458-470
-
-
Uehara, H.1
Kim, S.J.2
Karashima, T.3
-
12
-
-
0033022342
-
A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
-
CRAFT N, SHOSTAK Y, CAREY M, SAWYERS CL: A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat. Med. (1999) 5:280-285.
-
(1999)
Nat. Med.
, vol.5
, pp. 280-285
-
-
Craft, N.1
Shostak, Y.2
Carey, M.3
Sawyers, C.L.4
-
13
-
-
0033567003
-
Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model
-
MIYAKE H, TOLCHER A, GLEAVE ME: Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model. Cancer Res. (1999) 59:4030-4034.
-
(1999)
Cancer Res.
, vol.59
, pp. 4030-4034
-
-
Miyake, H.1
Tolcher, A.2
Gleave, M.E.3
-
14
-
-
0033978525
-
Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer
-
MIYAKE H, NELSON C, RENNIE PS, GLEAVE ME: Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res. (2000) 60:170-176.
-
(2000)
Cancer Res.
, vol.60
, pp. 170-176
-
-
Miyake, H.1
Nelson, C.2
Rennie, P.S.3
Gleave, M.E.4
-
15
-
-
0034213320
-
Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
-
MIYAKE H, POLLAK M, GLEAVE ME: Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Cancer Res. (2000) 60:3058-3064.
-
(2000)
Cancer Res.
, vol.60
, pp. 3058-3064
-
-
Miyake, H.1
Pollak, M.2
Gleave, M.E.3
-
16
-
-
0038756444
-
Castration-induced increase in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors
-
KIYAMA S, MORRISON K, ZELLWEGER T et al.: Castration-induced increase in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Cancer Res. (2003) 63:3575-3584.
-
(2003)
Cancer Res.
, vol.63
, pp. 3575-3584
-
-
Kiyama, S.1
Morrison, K.2
Zellweger, T.3
-
17
-
-
4644237335
-
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
-
ROCCHI P, SO A, KOJIMA S et al.: Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res. (2004) 64:6595-6602.
-
(2004)
Cancer Res.
, vol.64
, pp. 6595-6602
-
-
Rocchi, P.1
So, A.2
Kojima, S.3
-
18
-
-
0027093255
-
Expression of the protooncogene Bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
-
McDONNELL TJ, TRONCOSO P, BRISBAY SM et al.: Expression of the protooncogene Bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. (1992) 52:6940-6944.
-
(1992)
Cancer Res.
, vol.52
, pp. 6940-6944
-
-
Mcdonnell, T.J.1
Troncoso, P.2
Brisbay, S.M.3
-
19
-
-
0033565216
-
Castration-induced apoptosis of androgen-dependent Shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor binding proteins
-
NICKERSON T, MIYAKE H, GLEAVE ME, POLLAK M: Castration-induced apoptosis of androgen-dependent Shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor binding proteins. Cancer Res. (1999) 59:3392-3395.
-
(1999)
Cancer Res.
, vol.59
, pp. 3392-3395
-
-
Nickerson, T.1
Miyake, H.2
Gleave, M.E.3
Pollak, M.4
-
20
-
-
0034659691
-
Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense Bcl-xL and antisense Bcl-2 oligodeoxynucleotides plus taxol after castration in the Shionogi tumor model
-
MIYAKE H, MONIA BP, GLEAVE ME: Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense Bcl-xL and antisense Bcl-2 oligodeoxynucleotides plus taxol after castration in the Shionogi tumor model. Int. J. Cancer (2000) 86:855-862.
-
(2000)
Int. J. Cancer
, vol.86
, pp. 855-862
-
-
Miyake, H.1
Monia, B.P.2
Gleave, M.E.3
-
21
-
-
0037083472
-
Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy
-
JULY LV, AKBARI M, ZELLWEGER T, JONES EC, GOLDENBERG SL, GLEAVE ME: Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate (2002) 50:179-188.
-
(2002)
Prostate
, vol.50
, pp. 179-188
-
-
July, L.V.1
Akbari, M.2
Zellweger, T.3
Jones, E.C.4
Goldenberg, S.L.5
Gleave, M.E.6
-
22
-
-
0034455310
-
Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway
-
MIYAKE H, NELSON C, RENNIE PS, GLEAVE ME. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology (2000) 141:2257-2265.
-
(2000)
Endocrinology
, vol.141
, pp. 2257-2265
-
-
Miyake, H.1
Nelson, C.2
Rennie, P.S.3
Gleave, M.E.4
-
23
-
-
28044468839
-
A novel bispecific antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells
-
YAMANAKA K, ROCCHI P, MIYAKE H et al.: A novel bispecific antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells. Mol. Cancer Ther. (2005) 4:1688-1698.
-
(2005)
Mol. Cancer Ther.
, vol.4
, pp. 1688-1698
-
-
Yamanaka, K.1
Rocchi, P.2
Miyake, H.3
-
24
-
-
0029124742
-
Clusterin: Physiologic and pathophysiologic considerations
-
ROSENBERG ME, SILKENSEN J: Clusterin: physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. (1995) 27:633-645.
-
(1995)
Int. J. Biochem. Cell Biol.
, vol.27
, pp. 633-645
-
-
Rosenberg, M.E.1
Silkensen, J.2
-
25
-
-
0036829661
-
Clusterin/apolipoprotein J in human ageing and cancer
-
TROUGAKOS IP, GONOS ES: Clusterin/apolipoprotein J in human ageing and cancer. Int. J. Biochem. Cell Biol. (2002) 34:1430-1448.
-
(2002)
Int. J. Biochem. Cell Biol.
, vol.34
, pp. 1430-1448
-
-
Trougakos, I.P.1
Gonos, E.S.2
-
26
-
-
0034722899
-
Potential roles of antisense technology in cancer chemotherapy
-
CROOKE ST: Potential roles of antisense technology in cancer chemotherapy. Oncogene (2000) 19:6651-6659.
-
(2000)
Oncogene
, vol.19
, pp. 6651-6659
-
-
Crooke, S.T.1
-
27
-
-
0034026142
-
Antisense approaches enter the clinic
-
KHURI FR, KURIE JM: Antisense approaches enter the clinic. Clin. Cancer Res. (2000) 6:1607-1610.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 1607-1610
-
-
Khuri, F.R.1
Kurie, J.M.2
-
29
-
-
0032970584
-
Antisense oligonucleotiude therapeutics
-
BENNETT CF: Antisense oligonucleotiude therapeutics. Expert Opin. Investig. Drugs (1999) 8:237-253.
-
(1999)
Expert Opin. Investig. Drugs
, vol.8
, pp. 237-253
-
-
Bennett, C.F.1
-
30
-
-
0025887020
-
SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis
-
CONNOR J, BUTTYAN R, OLSSON CA, D'AGATI V, O'TOOLE K, SAWCZUK IS: SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int. (1991) 39:1098-1103.
-
(1991)
Kidney Int.
, vol.39
, pp. 1098-1103
-
-
Connor, J.1
Buttyan, R.2
Olsson, C.A.3
D'agati, V.4
O'toole, K.5
Sawczuk, I.S.6
-
31
-
-
0026088670
-
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
-
KYPRIANOU N, ENGLISH HF, DAVIDSON NE, ISSACS JT. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. (1991) 51:162-166.
-
(1991)
Cancer Res.
, vol.51
, pp. 162-166
-
-
Kyprianou, N.1
English, H.F.2
Davidson, N.E.3
Issacs, J.T.4
-
32
-
-
0025833074
-
Prostatic ductal system in rats: Regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2
-
SENSIBAR JA, GRISWOLD MD, SYLVESTER SR et al: Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology (1991) 128:2091-2102.
-
(1991)
Endocrinology
, vol.128
, pp. 2091-2102
-
-
Sensibar, J.A.1
Griswold, M.D.2
Sylvester, S.R.3
-
33
-
-
0022627063
-
Androgen-repressed messages in the rat ventral prostate
-
MONTPEIT ML, LAWLESS KR, TENNISWOOD M: Androgen-repressed messages in the rat ventral prostate. Prostate (1986) 8:25-36.
-
(1986)
Prostate
, vol.8
, pp. 25-36
-
-
Montpeit, M.L.1
Lawless, K.R.2
Tenniswood, M.3
-
34
-
-
0025246690
-
Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma
-
BRUCHOVSKY N, RENNIE PS, COLDMAN AJ, GOLDENBERG SL, TO M, LAWSON D: Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res. (1990) 50:2275-2282.
-
(1990)
Cancer Res.
, vol.50
, pp. 2275-2282
-
-
Bruchovsky, N.1
Rennie, P.S.2
Coldman, A.J.3
Goldenberg, S.L.4
To, M.5
Lawson, D.6
-
35
-
-
0025298231
-
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation
-
KYPRIANOU N, ENGLISH HF, ISAACS JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res. (1990) 50:3748-3753.
-
(1990)
Cancer Res.
, vol.50
, pp. 3748-3753
-
-
Kyprianou, N.1
English, H.F.2
Isaacs, J.T.3
-
36
-
-
0030064916
-
A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts
-
WRIGHT PS, CROSS-DOERSON D, TH'NG JP et al: A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts. Exp. Cell Res. (1996) 222:54-60.
-
(1996)
Exp. Cell Res.
, vol.222
, pp. 54-60
-
-
Wright, P.S.1
Cross-doerson, D.2
Th'ng, J.P.3
-
37
-
-
0033589283
-
Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue arrays
-
BUBENDORF L, KOLMER M, KONONEN J et al.: Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue arrays. J. Natl. Cancer Inst. (1999) 91:1758-1764.
-
(1999)
J. Natl. Cancer Inst.
, vol.91
, pp. 1758-1764
-
-
Bubendorf, L.1
Kolmer, M.2
Kononen, J.3
-
38
-
-
0034192382
-
Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models
-
MIYAKE H, NELSON C, RENNIE PS, GLEAVE ME: Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res. (2000) 60:2547-2554.
-
(2000)
Cancer Res.
, vol.60
, pp. 2547-2554
-
-
Miyake, H.1
Nelson, C.2
Rennie, P.S.3
Gleave, M.E.4
-
39
-
-
0034112089
-
Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo
-
MIYAKE H, CHI KN, GLEAVE ME: Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. (2000) 6:1655-1663.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 1655-1663
-
-
Miyake, H.1
Chi, K.N.2
Gleave, M.E.3
-
40
-
-
0036796026
-
Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin
-
ZELLWEGER T, CHI K, MIYAKE H et al.: Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin. Clin. Cancer Res. (2002) 8:3276-3284.
-
(2002)
Clin. Cancer Res.
, vol.8
, pp. 3276-3284
-
-
Zellweger, T.1
Chi, K.2
Miyake, H.3
-
41
-
-
0042912014
-
Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumor model
-
ZELLWEGER T, KIYAMA S, CHI K et al: Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumor model. BJU Int. (2003) 92:463-469.
-
(2003)
BJU Int.
, vol.92
, pp. 463-469
-
-
Zellweger, T.1
Kiyama, S.2
Chi, K.3
-
42
-
-
9444288705
-
Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of cluterin and its modulation by androgen
-
MIYAKE H, HARA I, GLEAVE ME, ETO H: Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of cluterin and its modulation by androgen. Prostate (2004) 61:318-323.
-
(2004)
Prostate
, vol.61
, pp. 318-323
-
-
Miyake, H.1
Hara, I.2
Gleave, M.E.3
Eto, H.4
-
43
-
-
14844293486
-
Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model
-
YAMANAKA K, GLEAVE ME, HARA I, MURAMAKI M, MIYAKE H: Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model. Mol. Cancer Ther. (2005) 4:187-195.
-
(2005)
Mol. Cancer Ther.
, vol.4
, pp. 187-195
-
-
Yamanaka, K.1
Gleave, M.E.2
Hara, I.3
Muramaki, M.4
Miyake, H.5
-
44
-
-
27744552075
-
Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer
-
MIYAKE H, YAMANAKA K, MURAMAKI M, KURAHASHI T, GLEAVE M, HARA I: Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer. Oncol. Rep. (2005) 14:1371-1375.
-
(2005)
Oncol. Rep.
, vol.14
, pp. 1371-1375
-
-
Miyake, H.1
Yamanaka, K.2
Muramaki, M.3
Kurahashi, T.4
Gleave, M.5
Hara, I.6
-
45
-
-
0030843011
-
Intracellular levels of'SGP-2 (clusterin) correlate with tumor grade in prostate cancer
-
STEINBERG J, OYASU R, LANG S et al.: Intracellular levels of'SGP-2 (clusterin) correlate with tumor grade in prostate cancer. Clin. Cancer Res. (1997) 3:1707-1711.
-
(1997)
Clin. Cancer Res.
, vol.3
, pp. 1707-1711
-
-
Steinberg, J.1
Oyasu, R.2
Lang, S.3
-
46
-
-
15944373057
-
Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason score: A preliminary report
-
PINS MR, FIADJOE JE, KORLEY F et al.: Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason score: a preliminary report. Prostate Cancer Prostatic Dis. (2004) 7:243-248.
-
(2004)
Prostate Cancer Prostatic Dis.
, vol.7
, pp. 243-248
-
-
Pins, M.R.1
Fiadjoe, J.E.2
Korley, F.3
-
47
-
-
0031748528
-
Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties
-
SCHWOCHAU GB, NATH KA, ROSENBERG ME: Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int. (1998) 53:1647-1653.
-
(1998)
Kidney Int.
, vol.53
, pp. 1647-1653
-
-
Schwochau, G.B.1
Nath, K.A.2
Rosenberg, M.E.3
-
48
-
-
0028210028
-
Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death
-
FRENCH LE, WOHLWEND A, SAPPINO AF, TSCHOPP J, SCHIFFERLI JA: Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin. Investig. (1994) 93:877-884.
-
(1994)
J. Clin. Investig.
, vol.93
, pp. 877-884
-
-
French, L.E.1
Wohlwend, A.2
Sappino, A.F.3
Tschopp, J.4
Schifferli, J.A.5
-
49
-
-
0026469891
-
Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus
-
FRENCH LE, SAPPINO AP, TSCHOPP J, SCHIFFERLI JA: Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J. Clin. Investig. (1992) 90:1919-1925.
-
(1992)
J. Clin. Investig.
, vol.90
, pp. 1919-1925
-
-
French, L.E.1
Sappino, A.P.2
Tschopp, J.3
Schifferli, J.A.4
-
50
-
-
26944445883
-
Clusterin inhibits apoptosis by interacting with activated Bax
-
ZHANG H, KIM JK, EDWARDS CA, XU Z, TAICHMAN R, WANG CY: Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. (2005) 7:909-915.
-
(2005)
Nat. Cell Biol.
, vol.7
, pp. 909-915
-
-
Zhang, H.1
Kim, J.K.2
Edwards, C.A.3
Xu, Z.4
Taichman, R.5
Wang, C.Y.6
-
51
-
-
2342566706
-
Repression of IR-inducible clusterin expression by the p53 tumour suppressor protein
-
CRISWELL T, KLOKOV D, BEMAN M, LAVIK JP, BOOTHMAN DA: Repression of IR-inducible clusterin expression by the p53 tumour suppressor protein. Cancer Biol. Ther. (2003) 2:372-380.
-
(2003)
Cancer Biol. Ther.
, vol.2
, pp. 372-380
-
-
Criswell, T.1
Klokov, D.2
Beman, M.3
Lavik, J.P.4
Boothman, D.A.5
-
52
-
-
0034647738
-
Direct transactivation of the antiapoptotic gene apolipoprotein J (clusterin) by B-MYB
-
CERVELLERA M, RASCHELLA G, SANTILLI G et al.: Direct transactivation of the antiapoptotic gene apolipoprotein J (clusterin) by B-MYB. J. Biol. Chem. (2000) 275:21055-21060.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 21055-21060
-
-
Cervellera, M.1
Raschella, G.2
Santilli, G.3
-
53
-
-
0141643351
-
Essential requirement of apolipoprotein J (clusterin) signaling for IκB expression and regulation of NF-κB activity
-
SANKILL G, ARONOW BJ, SALA A: Essential requirement of apolipoprotein J (clusterin) signaling for IκB expression and regulation of NF-κB activity. J. Biol. Chem. (2003) 278:38214-38219.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 38214-38219
-
-
Sankill, G.1
Aronow, B.J.2
Sala, A.3
-
55
-
-
11244308115
-
Isolation and characterization of a novel gene CLUAP1 whose expression is frequently upregulated in colon cancer
-
TAKAHASHI M, LIN YM, NAKAMURA Y, FURUKAWA Y: Isolation and characterization of a novel gene CLUAP1 whose expression is frequently upregulated in colon cancer. Oncogene (2004) 9:9289-9294.
-
(2004)
Oncogene
, vol.9
, pp. 9289-9294
-
-
Takahashi, M.1
Lin, Y.M.2
Nakamura, Y.3
Furukawa, Y.4
-
56
-
-
0030664673
-
Stress-induced transcription of the clusterinl apo J gene
-
MICHEL D, CHATELAIN G, NORTH S, BRUN G: Stress-induced transcription of the clusterinl apo J gene. Biochem. J. (1997) 328:45-50.
-
(1997)
Biochem. J.
, vol.328
, pp. 45-50
-
-
Michel, D.1
Chatelain, G.2
North, S.3
Brun, G.4
-
57
-
-
15944390264
-
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer
-
GLEAVE M, MIYAKE H: Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer. World J. Urol. (2005) 23:38-46.
-
(2005)
World J. Urol.
, vol.23
, pp. 38-46
-
-
Gleave, M.1
Miyake, H.2
-
58
-
-
28444443360
-
Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic
-
MIYAKE H, HARA I, GLEAVE ME: Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic. Int. J. Urol. (2005) 12:785-794.
-
(2005)
Int. J. Urol.
, vol.12
, pp. 785-794
-
-
Miyake, H.1
Hara, I.2
Gleave, M.E.3
-
59
-
-
5644249330
-
Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent
-
CHEN T, TURNER J, McCARTHY S, SCALTRITI M, BETTUZZI S, YEATMAN TJ: Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. Cancer Res. (2004) 64:7412-7419.
-
(2004)
Cancer Res.
, vol.64
, pp. 7412-7419
-
-
Chen, T.1
Turner, J.2
Mccarthy, S.3
Scaltriti, M.4
Bettuzzi, S.5
Yeatman, T.J.6
-
60
-
-
10844290787
-
Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis
-
SCALTRITI M, BETTUZZI S, SHARRARD RM, CAPORALI A, CACCAMO AE, MAITLAND NJ: Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis. Br. J. Cancer (2004) 91:1842-18 50.
-
(2004)
Br. J. Cancer
, vol.91
, pp. 1842-1850
-
-
Scaltriti, M.1
Bettuzzi, S.2
Sharrard, R.M.3
Caporali, A.4
Caccamo, A.E.5
Maitland, N.J.6
-
61
-
-
4344616635
-
Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells
-
SCALTRITI M, SANTAMARIA A, PACIUCCI R, BETTUZZI S: Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells. Cancer Res. (2004) 64:6174-6182.
-
(2004)
Cancer Res.
, vol.64
, pp. 6174-6182
-
-
Scaltriti, M.1
Santamaria, A.2
Paciucci, R.3
Bettuzzi, S.4
-
62
-
-
0037837729
-
Synthesis and functional analyses of nuclear clusterin, a cell death protein
-
LESKOV KS, KLOKOV DY, LI J, KINSELLA TJ, BOOTHMAN DA: Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. (2003) 278:11590-11600.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 11590-11600
-
-
Leskov, K.S.1
Klokov, D.Y.2
Li, J.3
Kinsella, T.J.4
Boothman, D.A.5
-
63
-
-
1842589298
-
Modulation of different clusterin isoforms in human colon tumorigenesis
-
PUCCI S, BONANNO E, PICHIORRI F, ANGELONI C, SPAGNOLI LG: Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene (2004) 23:2298-2304.
-
(2004)
Oncogene
, vol.23
, pp. 2298-2304
-
-
Pucci, S.1
Bonanno, E.2
Pichiorri, F.3
Angeloni, C.4
Spagnoli, L.G.5
-
64
-
-
0034705103
-
Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death
-
YANG CR, LESKOV K, HOSLEY-EBERLEIN K et al.: Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death. Proc. Natl. Acad. Sci. USA (2000) 97:5907-5912.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 5907-5912
-
-
Yang, C.R.1
Leskov, K.2
Hosley-eberlein, K.3
-
65
-
-
0042665410
-
Alternations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis
-
O'SULLIVAN J, WHYTE L, DRAKE J, TENNISWOOD M: Alternations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ. (2003) 10:914-927.
-
(2003)
Cell Death Differ.
, vol.10
, pp. 914-927
-
-
O'Sullivan, J.1
Whyte, L.2
Drake, J.3
Tenniswood, M.4
-
66
-
-
0029871768
-
Transforming growth factor β (TGF-β)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells
-
REDDY KB, JIN G, KARODE MC, HARMONY JA, HOWE PH: Transforming growth factor β (TGF-β)-induced nuclear localization of apolipoprotein J/ clusterin in epithelial cells. Biochemistry (1996) 35:6157-6163.
-
(1996)
Biochemistry
, vol.35
, pp. 6157-6163
-
-
Reddy, K.B.1
Jin, G.2
Karode, M.C.3
Harmony, J.A.4
Howe, P.H.5
-
67
-
-
0036892878
-
Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoprosis in prostate and bladder cancer cells
-
WU AJ, PARK II, ZHAUNG L, LEE C: Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoprosis in prostate and bladder cancer cells. Prostate (2002) 53:277-285.
-
(2002)
Prostate
, vol.53
, pp. 277-285
-
-
Wu, A.J.1
Park, I.I.2
Zhaung, L.3
Lee, C.4
-
68
-
-
0029061350
-
Prevention of cell death induced by tumor necrosis factor α in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin)
-
SENSIBAR JA, SUTKOWSKI DM, RAFFO A et al.: Prevention of cell death induced by tumor necrosis factor α in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res. (1995) 55:2431-2437.
-
(1995)
Cancer Res.
, vol.55
, pp. 2431-2437
-
-
Sensibar, J.A.1
Sutkowski, D.M.2
Raffo, A.3
-
69
-
-
0037810710
-
Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression
-
MIYAKE H, HARA I, KAMIDONO S, GLEAVE ME, ETO H: Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol. Rep. (2003) 10:469-473.
-
(2003)
Oncol. Rep.
, vol.10
, pp. 469-473
-
-
Miyake, H.1
Hara, I.2
Kamidono, S.3
Gleave, M.E.4
Eto, H.5
-
70
-
-
1642282641
-
Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress
-
TROUGAKOS IP, SO A, JANSEN B, GLEAVE ME, GONOS ES: Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res. (2004) 64:1834-1842.
-
(2004)
Cancer Res.
, vol.64
, pp. 1834-1842
-
-
Trougakos, I.P.1
So, A.2
Jansen, B.3
Gleave, M.E.4
Gonos, E.S.5
-
71
-
-
4444222462
-
Nucleotide-based therapies targeting clusterin chemosensitizes human lung adenocarcinoma cells both in vitro and in vivo
-
JULY LV, BERALDI E, SO AI et al.: Nucleotide-based therapies targeting clusterin chemosensitizes human lung adenocarcinoma cells both in vitro and in vivo. Mol. Cancer Ther. (2004) 3:223-232.
-
(2004)
Mol. Cancer Ther.
, vol.3
, pp. 223-232
-
-
July, L.V.1
Beraldi, E.2
So, A.I.3
-
72
-
-
0033903190
-
Overexpression of clusterin in human breast carcinoma
-
REDONDO M, VILLAR E, TORRES-MUNOZ J, TELLEZ T, MORELL M, PETITO CK: Overexpression of clusterin in human breast carcinoma. Am. J. Pathol. (2000) 157:393-399.
-
(2000)
Am. J. Pathol.
, vol.157
, pp. 393-399
-
-
Redondo, M.1
Villar, E.2
Torres-munoz, J.3
Tellez, T.4
Morell, M.5
Petito, C.K.6
-
73
-
-
0035872441
-
Coordinately up-regulated genes in ovarian cancer
-
HOUGH CD, CHO KR, ZONDERMAN AB, SCHWARTZ DR, MORIN PJ: Coordinately up-regulated genes in ovarian cancer. Cancer Res. (2001) 61:3869-3876.
-
(2001)
Cancer Res.
, vol.61
, pp. 3869-3876
-
-
Hough, C.D.1
Cho, K.R.2
Zonderman, A.B.3
Schwartz, D.R.4
Morin, P.J.5
-
74
-
-
0036144277
-
Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence
-
MIYAKE H, GLEAVE M, KAMIDONO S, HARA I: Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence. Urology (2002) 59:150-154.
-
(2002)
Urology
, vol.59
, pp. 150-154
-
-
Miyake, H.1
Gleave, M.2
Kamidono, S.3
Hara, I.4
-
75
-
-
0036143452
-
Over expression of clusterin is an independent prognostic factor for non-papillary renal cell carcinoma
-
MIYAKE H, HARA S, ARAKAWA S, KAMIDONO S, HARA I: Over expression of clusterin is an independent prognostic factor for non-papillary renal cell carcinoma. J. Urol. (2002) 167:703-706.
-
(2002)
J. Urol.
, vol.167
, pp. 703-706
-
-
Miyake, H.1
Hara, S.2
Arakawa, S.3
Kamidono, S.4
Hara, I.5
-
76
-
-
25844444617
-
Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension
-
KURAHASHI T, MURAMAKI M, YAMANAKA K, HARA I, MIYAKE H: Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension. BJU Int. (2005) 96:895-899.
-
(2005)
BJU Int.
, vol.96
, pp. 895-899
-
-
Kurahashi, T.1
Muramaki, M.2
Yamanaka, K.3
Hara, I.4
Miyake, H.5
-
77
-
-
0035675829
-
Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model
-
MIYAKE H, HARA I. KAMIDONO S, GLEAVE ME: Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin. Cancer Res. (2001) 7:4245-4252.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 4245-4252
-
-
Miyake, H.1
Hara, I.2
Kamidono, S.3
Gleave, M.E.4
-
78
-
-
2442565896
-
Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer KoTCC- I cells
-
MIYAKE H, ETO H, HARA I, SO A, LI D, GLEAVE ME: Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer KoTCC- I cells. J. Urol. (2004) 171:2477-2481.
-
(2004)
J. Urol.
, vol.171
, pp. 2477-2481
-
-
Miyake, H.1
Eto, H.2
Hara, I.3
So, A.4
Li, D.5
Gleave, M.E.6
-
79
-
-
14644404957
-
Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model
-
MIYAKE H, YAMANAKA K, MURAMAKI M, HARA I, GLEAVE ME: Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Neoplasia (2005) 7:171-179.
-
(2005)
Neoplasia
, vol.7
, pp. 171-179
-
-
Miyake, H.1
Yamanaka, K.2
Muramaki, M.3
Hara, I.4
Gleave, M.E.5
-
80
-
-
0034870685
-
Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the anti-apoptotic gene clusterin
-
ZELLWEGER T, MIYAKE H, JULY LV, AKBARI M, KIYAMA S, GLEAVE ME: Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the anti-apoptotic gene clusterin. Neoplasia (2001) 3:360-367.
-
(2001)
Neoplasia
, vol.3
, pp. 360-367
-
-
Zellweger, T.1
Miyake, H.2
July, L.V.3
Akbari, M.4
Kiyama, S.5
Gleave, M.E.6
-
81
-
-
0023447259
-
Selective elimination of mRNAs in vivo: Complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity
-
DASH P, LOTAN I, KNAPP M, KANDEL ER, GOELET P: Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity. Proc. Natl. Acad. Sci. USA (1987) 84:7896-7900.
-
(1987)
Proc. Natl. Acad. Sci. USA
, vol.84
, pp. 7896-7900
-
-
Dash, P.1
Lotan, I.2
Knapp, M.3
Kandel, E.R.4
Goelet, P.5
-
82
-
-
0027284424
-
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides
-
DOMINSKI Z, KOLE R: Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA (1993) 90:8673-8677.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 8673-8677
-
-
Dominski, Z.1
Kole, R.2
-
83
-
-
0025312339
-
Tumor-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide
-
McMANAWAY ME, NECKERS LM, LOKE SL et al.: Tumor-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet (1990) 335:808-811.
-
(1990)
Lancet
, vol.335
, pp. 808-811
-
-
McManaway, M.E.1
Neckers, L.M.2
Loke, S.L.3
-
84
-
-
0024517255
-
Inhibition ofexpression of SV40 virus large T-antigen by antisense oligodeoxyribonucleotides
-
WESTERMANN P, GROSS B, HOINKIS G: Inhibition ofexpression of SV40 virus large T-antigen by antisense oligodeoxyribonucleotides. Biomed. Biochim. Acta (1989) 48:85-93.
-
(1989)
Biomed. Biochim. Acta
, vol.48
, pp. 85-93
-
-
Westermann, P.1
Gross, B.2
Hoinkis, G.3
-
85
-
-
0026648540
-
Modulation of eukaryotic initiation factof-4E binding to 5′-capped oligoribonucleotides by modified antisense oligonucleotides
-
BAKER BF, MIRAGLIA L, HAGEDORN CH: Modulation of eukaryotic initiation factof-4E binding to 5′-capped oligoribonucleotides by modified antisense oligonucleotides. J. Biol. Chem. (1992) 267:11495-11499.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 11495-11499
-
-
Baker, B.F.1
Miraglia, L.2
Hagedorn, C.H.3
-
87
-
-
0011836520
-
Structural modifications toward improved antisense oligonucleotides
-
MATTEUCCI M: Structural modifications toward improved antisense oligonucleotides. Perspectives Drug Dis. Des. (1996) 4:1-16.
-
(1996)
Perspectives Drug Dis. Des.
, vol.4
, pp. 1-16
-
-
Matteucci, M.1
-
88
-
-
0022428810
-
Reversed-phase high-performance liquid chromatographic separation of diastereomeric phosphorothioate analogues of oligodeoxyribonucleotides and other backbone-modified congeners of DNA
-
STEC WJ, ZON G, UZANSKI B: Reversed-phase high-performance liquid chromatographic separation of diastereomeric phosphorothioate analogues of oligodeoxyribonucleotides and other backbone-modified congeners of DNA. J. Chromatogr. (1985) 326:263-280.
-
(1985)
J. Chromatogr.
, vol.326
, pp. 263-280
-
-
Stec, W.J.1
Zon, G.2
Uzanski, B.3
-
89
-
-
0029977448
-
Antitumor activity of a phosphorothioate antisense oligodeoxynucletide targeted against C-raf kinase
-
MONIA BP, JOHNSTON JE GEIGER T, MULLER M, FABBRO D: Antitumor activity of a phosphorothioate antisense oligodeoxynucletide targeted against C-raf kinase. Nat. Med. (1996) 2:668-675.
-
(1996)
Nat. Med.
, vol.2
, pp. 668-675
-
-
Monia, B.P.1
Johnston, J.E.2
Geiger, T.3
Muller, M.4
Fabbro, D.5
-
90
-
-
25144436540
-
Enhanced radiosensitivity by inhibition of the antiapoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model
-
YAMANAKA K, GLEAVE M, MURAMAKI M, HARA I, MIYAKE H: Enhanced radiosensitivity by inhibition of the antiapoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model. Oncol. Rep. (2005) 13:885-890.
-
(2005)
Oncol. Rep.
, vol.13
, pp. 885-890
-
-
Yamanaka, K.1
Gleave, M.2
Muramaki, M.3
Hara, I.4
Miyake, H.5
-
91
-
-
0034606686
-
Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides
-
MIYAKE H, TOLCHER A, GLEAVE ME: Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides. J. Natl. Cancer Inst. (2000) 92:34-41.
-
(2000)
J. Natl. Cancer Inst.
, vol.92
, pp. 34-41
-
-
Miyake, H.1
Tolcher, A.2
Gleave, M.E.3
-
92
-
-
0035869667
-
Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model
-
LEUNG S, MIYAKE H, ZELLWEGER T, TOLCHER A, GLEAVE ME: Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model. Int. J. Cancer (2001) 91:846-850.
-
(2001)
Int. J. Cancer
, vol.91
, pp. 846-850
-
-
Leung, S.1
Miyake, H.2
Zellweger, T.3
Tolcher, A.4
Gleave, M.E.5
-
93
-
-
0034013539
-
Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin but not by glycosylation inhibitor, tunicamycin in human prostate cancer cells
-
MIYAKE H, HARA I, ARAKAWA S, KAMIDONO S: Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin but not by glycosylation inhibitor, tunicamycin in human prostate cancer cells. J. Cell. Biochem. (2000) 77:396-408.
-
(2000)
J. Cell. Biochem.
, vol.77
, pp. 396-408
-
-
Miyake, H.1
Hara, I.2
Arakawa, S.3
Kamidono, S.4
-
94
-
-
0032741282
-
Progression to androgen-independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model
-
GLEAVE M, TOLCHER A, MIYAKE H et al: Progression to androgen-independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. Clin. Cancer Res. (1999) 5:2891-2898.
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 2891-2898
-
-
Gleave, M.1
Tolcher, A.2
Miyake, H.3
-
95
-
-
0028019410
-
Gene inhibition using antisense oligodeoxynucleotides
-
WAGNER RW. Gene inhibition using antisense oligodeoxynucleotides. Nature (1994) 372:333-335.
-
(1994)
Nature
, vol.372
, pp. 333-335
-
-
Wagner, R.W.1
-
96
-
-
0027168725
-
Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression
-
MONIA BP, LESNIK EA, GONZALEZ C et al.: Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. (1993) 268:14514-14522.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 14514-14522
-
-
Monia, B.P.1
Lesnik, E.A.2
Gonzalez, C.3
-
97
-
-
0029867162
-
Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-α by the incorporation of 2′-O-propyl modifications
-
McKAY RA, CUMMINS LL, GRAHAM MJ et al: Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-α by the incorporation of 2′-O-propyl modifications. Nucleic Acids Res. (1996) 24:411-417.
-
(1996)
Nucleic Acids Res.
, vol.24
, pp. 411-417
-
-
McKay, R.A.1
Cummins, L.L.2
Graham, M.J.3
-
98
-
-
0034883854
-
Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry
-
ZELLWEGER T, MIYAKE H, COOPER S et al.: Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry. J. Pharmacol. Exp. Ther. (2001) 298:934-940.
-
(2001)
J. Pharmacol. Exp. Ther.
, vol.298
, pp. 934-940
-
-
Zellweger, T.1
Miyake, H.2
Cooper, S.3
-
100
-
-
21744452813
-
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel in prostate cancer xenograft models
-
SPRINGATE CM, JACKSON JK, GLEAVE ME, BURT HM: Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel in prostate cancer xenograft models. Cancer Chemother. Pharmacol. (2005) 56:239-247.
-
(2005)
Cancer Chemother. Pharmacol.
, vol.56
, pp. 239-247
-
-
Springate, C.M.1
Jackson, J.K.2
Gleave, M.E.3
Burt, H.M.4
-
101
-
-
28744438393
-
The inhibition of angiogenesis by antisense oligonucleotides to clusterin
-
JACKSON JK, GLEAVE ME, GLEAVE J, BURT HM: The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis (2005) 8:229-238.
-
(2005)
Angiogenesis
, vol.8
, pp. 229-238
-
-
Jackson, J.K.1
Gleave, M.E.2
Gleave, J.3
Burt, H.M.4
-
102
-
-
24744470522
-
A Phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethl antisense oligonucleotide of clusterin, in patients with localized prostate cancer
-
CHI KN, EISENHAUER E, FAZLI L et al.: A Phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethl antisense oligonucleotide of clusterin, in patients with localized prostate cancer. J. Natl. Cancer Inst. (2005) 97:1287-1296.
-
(2005)
J. Natl. Cancer Inst.
, vol.97
, pp. 1287-1296
-
-
Chi, K.N.1
Eisenhauer, E.2
Fazli, L.3
-
103
-
-
30344436175
-
A Phase I study of a second generation antisense oligonucleotide to clusterin (OGX-011) in combination with docetaxel: NCIC CTG IND. 154
-
CHI KN, EISENHAUER E, SIU L et al: A Phase I study of a second generation antisense oligonucleotide to clusterin (OGX-011) in combination with docetaxel: NCIC CTG IND. 154. J. Clin. Oncol. (2005) 23:213S.
-
(2005)
J. Clin. Oncol.
, vol.23
-
-
Chi, K.N.1
Eisenhauer, E.2
Siu, L.3
-
104
-
-
23844543479
-
Antisense oligonucleotides: The state of the art
-
ABOUL-FADL T. Antisense oligonucleotides: the state of the art. Curr. Med. Chem. (2005) 12:2193-2214.
-
(2005)
Curr. Med. Chem.
, vol.12
, pp. 2193-2214
-
-
Aboul-Fadl, T.1
-
105
-
-
26844431930
-
Peptide nucleic acids (PNAs), a chemical overview
-
PORCHEDDU A, GIACOMELLI G: Peptide nucleic acids (PNAs), a chemical overview. Curr. Med. Chem. (2005) 12:2561-2599.
-
(2005)
Curr. Med. Chem.
, vol.12
, pp. 2561-2599
-
-
Porcheddu, A.1
Giacomelli, G.2
-
106
-
-
0034096268
-
A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells
-
ZANGEMEISTER-WITTKE U, LEECH SH, OLIE RA et al: A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells. Clin. Cancer Res. (2000) 6:2547-2555.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 2547-2555
-
-
Zangemeister-Wittke, U.1
Leech, S.H.2
Olie, R.A.3
-
107
-
-
0035925537
-
Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins
-
GAUTSCHI O, TSCHOPP S, OLIE RA et al: Activity of a novel bcl-2/ bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. J. Natl. Cancer Inst. (2001) 93:463-471.
-
(2001)
J. Natl. Cancer Inst.
, vol.93
, pp. 463-471
-
-
Gautschi, O.1
Tschopp, S.2
Olie, R.A.3
-
108
-
-
0028958031
-
Insulin-like growth factors and their binding proteins: Biological actions
-
JONES JI, CLEMMONS DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. (1995) 16:3-34.
-
(1995)
Endocr. Rev.
, vol.16
, pp. 3-34
-
-
Jones, J.I.1
Clemmons, D.R.2
-
110
-
-
0030772022
-
Target to apoptosis: A hopeful weapon for prostate cancer
-
TANG DG, PORTER AT. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate (1997) 32:284-293.
-
(1997)
Prostate
, vol.32
, pp. 284-293
-
-
Tang, D.G.1
Porter, A.T.2
-
111
-
-
0032730633
-
Phase I study of an antisense oligonucleotide to protein-kinase C-α (ISIS3521/CGP64128A) in patients with cancer
-
YUEN AR, HALSEY J, FISHER GA et al.: Phase I study of an antisense oligonucleotide to protein-kinase C-α (ISIS3521/CGP64128A) in patients with cancer. Clin. Cancer Res. (1999) 5:3357-3363.
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 3357-3363
-
-
Yuen, A.R.1
Halsey, J.2
Fisher, G.A.3
-
112
-
-
0034720202
-
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
-
KONDO Y, KOGA S, KOMATA T, KONDO S: Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. Oncogene (2000) 19:2205-2211.
-
(2000)
Oncogene
, vol.19
, pp. 2205-2211
-
-
Kondo, Y.1
Koga, S.2
Komata, T.3
Kondo, S.4
|